User:Mr. Ibrahem/Romosozumab

Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis. It decreases the risk of fractures of the spine. It is used by injection under the skin.

Common side effect include headache, joint pain, and allergic reactions. It may increase the risk of heart attacks and strokes. Other side effects may include low calcium. It is a monoclonal antibody that attaching to and blocks sclerostin. This increases bone formation and reduces bone breakdown.

Romosozumab was approved for medical use in the United States and Europe in 2019. In the United States it costs about $2,050 a month as of 2021. This amount in the United Kingdom costs the NHS about £430.